EFFECTS OF MUSCARINIC RECEPTOR AGONISTS AND ANTAGONISTS ON RAT-BRAIN SEROTONERGIC ACTIVITY

被引:6
作者
BHATTACHARYA, SK
SEN, AP
机构
[1] Neuropharmacology Laboratory, Department of Pharmacology, Institute of Medical Sciences, Banaras Hindu University, Varanasi
关键词
MUSCARINIC RECEPTORS; M1-AGONISTS ANTAGONISTS AND M2-AGONISTS ANTAGONISTS; 5-HT; 5-HIAA; RAT BRAIN;
D O I
10.1007/BF01250965
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The effects of some muscarinic M1 and M2 receptor agonists and antagonists on rat brain serotonergic activity was assessed by noting their effects on the levels of 5-hydroxytryptamine (5-HT) and its major metabolite, 5-hydroxyindole acetic acid (5-HIAA), estimated by a high pressure-liquid chromatographic (HPLC) technique. The muscarinic M2 receptor agonists, arecholine and McN-A-343, and the M2 receptor agonists, gallamine and AF-DX 116, induced a dose-related decrease in the concentrations of both 5-HT and 5-HIAA. On the contrary, scopolamine and the selective M1 receptor antagonist, pirenzepine, increased the levels of the amine and its metabolite. The anti-cholinesterase agent, physostigmine, and the putative M2 receptor agonist, carbachol, induced a dose-related dual effect, with the smaller doses decreasing and the higher doses increasing 5-HT and 5-HIAA concentrations. The results indicate that an inverse relationship exists between the cholinergic and serotonergic neurotransmitter systems in the rat brain due to the likely presence of muscarinic heteroreceptors on serotonergic neurones. The data also indicates that though physostigmine and carbachol may function as M2 receptor agonists, they lose their receptor specificity on dose increment.
引用
收藏
页码:241 / 247
页数:7
相关论文
共 26 条
  • [1] ARAI H, 1984, J NEUROCHEM, V43, P388
  • [2] BHATTACHARYA S K, 1991, Journal of Psychopharmacology, V5, P77, DOI 10.1177/026988119100500111
  • [3] EFFECTS OF MUSCARINIC RECEPTOR AGONISTS AND ANTAGONISTS ON DOPAMINE-MEDIATED BEHAVIORAL PARADIGMS
    BHATTACHARYA, SK
    SEN, AP
    [J]. JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION, 1991, 84 (03) : 241 - 246
  • [4] BHATTACHARYA SK, 1991, INDIAN J EXP BIOL, V29, P237
  • [5] BHATTACHARYA SK, 1992, BIOGENIC AMINES, V8, P309
  • [6] CENTRAL MUSCARINIC RECEPTOR SUBTYPES AND CARRAGEENAN-INDUCED PAW EDEMA IN RATS
    BHATTACHARYA, SK
    SEN, AP
    DASGUPTA, G
    SETH, K
    SETH, PK
    [J]. RESEARCH IN EXPERIMENTAL MEDICINE, 1991, 191 (01) : 65 - 76
  • [7] BHATTACHARYA SK, 1991, INDIAN J EXP BIOL, V29, P131
  • [8] MUSCARINIC RECEPTOR ACTIVATION INHIBITS BOTH RELEASE AND SYNTHESIS OF NORADRENALINE IN RAT HIPPOCAMPAL SYNAPTOSOMES
    BIRCH, PJ
    FILLENZ, M
    [J]. NEUROCHEMISTRY INTERNATIONAL, 1986, 8 (02) : 171 - 177
  • [9] ALZHEIMERS-DISEASE - A DISORDER OF CORTICAL CHOLINERGIC INNERVATION
    COYLE, JT
    PRICE, DL
    DELONG, MR
    [J]. SCIENCE, 1983, 219 (4589) : 1184 - 1190
  • [10] NEUROTRANSMITTER RECEPTORS AND MONOAMINE METABOLITES IN THE BRAINS OF PATIENTS WITH ALZHEIMER-TYPE DEMENTIA AND DEPRESSION, AND SUICIDES
    CROW, TJ
    CROSS, AJ
    COOPER, SJ
    DEAKIN, JFW
    FERRIER, IN
    JOHNSON, JA
    JOSEPH, MH
    OWEN, F
    POULTER, M
    LOFTHOUSE, R
    CORSELLIS, JAN
    CHAMBERS, DR
    BLESSED, G
    PERRY, EK
    PERRY, RH
    TOMLINSON, BE
    [J]. NEUROPHARMACOLOGY, 1984, 23 : 1561 - 1569